TRUXIMA

Indicated For

Non-Hodgkin’s lymphoma, Chronic lymphocytic leukemia, Granulomatosis with polyangiitis, Microscopic polyangiitis, Rheumatoid arthritis

About This Medication

# TRUXIMA (rituximab-abbs) Cost Support Program Patient Guide: How to Get TRUXIMA at Low or No Cost TRUXIMA (rituximab-abbs) is a biosimilar prescription medicine used to treat certain adults with **Non-Hodgkin's Lymphoma (NHL)**, **Chronic Lymphocytic Leukemia (CLL)**, and **Rheumatoid Arthritis (RA)**. This patient-friendly guide explains the Teva **TRUXIMA Cost Support Program** (also called the Copay Card program), which helps **commercially insured patients** pay as little as **$0** for eligible out-of-pocket costs—but it's **not** a full patient assistance program (PAP) for uninsured or low-income patients.[1][2][4][5] ## About TRUXIMA and Why Cost Support Matters **TRUXIMA** is an injectable biosimilar to Rituxan (rituximab), meaning it's highly similar in safety, effectiveness, and quality. It's FDA-approved for: - **NHL**: Alone or with chemotherapy. - **CLL**: With fludarabine and cyclophosphamide. - **RA**: With methotrexate, after TNF antagonists didn't work well.[4][5] TRUXIMA is given by a healthcare provider via IV infusion, often in a clinic or hospital. Costs can be high due to out-of-pocket copays, coinsurance, or deductibles—especially for medical benefit administrations. The Cost Support Program reduces these costs for eligible patients, but it **does not cover** office visits, tests, or other expenses.[1] **Important Safety Note**: TRUXIMA has a Boxed Warning for fatal infusion reactions, tumor lysis syndrome, severe mucocutaneous reactions, hepatitis B reactivation, and progressive multifocal leukoencephalopathy (PML). Tell your doctor about heart, lung, kidney issues, infections, or prior rituximab reactions. Watch for symptoms like confusion, weakness, dizziness, or vision problems.[4][5] ## Who Qualifies for the TRUXIMA Cost Support Program? This program is a **copay assistance card** for **commercially insured patients only**. You **do not** qualify if: - Uninsured or cash-paying.[1] - On government insurance like **Medicare, Medicaid**, or VA.[1] - Enrolled in employer-sponsored retiree plans or certain health plans that prohibit copay cards.[1] **Key Eligibility**: - Valid TRUXIMA prescription. - Commercial insurance covering TRUXIMA (pharmacy or medical benefit). - U.S. resident (including territories).[1][2] There are **no income requirements**—it's not based on finances like traditional PAPs. However, annual benefit limits apply per individual; you'll pay full costs after reaching the cap.[1] **Income Eligibility Breakdown**: Since this is copay-only (no income test), here's a simple table comparing to typical PAPs: | Household Size | Typical PAP (e.g., 400-500% FPL) | TRUXIMA Program | |---------------|---------------------------------|------------------| | Individual | ~$60,000-$75,000/year | No limit; commercial insurance only[1] | | Couple | ~$80,000-$100,000/year | No limit; commercial insurance only[1] | | Family of 3 | ~$100,000-$125,000/year | No limit; commercial insurance only[1] | | Family of 4 | ~$120,000-$150,000/year | No limit; commercial insurance only[1] | *Notes*: FPL = Federal Poverty Level (2026 estimates). TRUXIMA has **no PAP** for low-income/uninsured; explore alternatives below.[1] ## Insurance Requirements **Commercial insurance only**—must cover TRUXIMA via pharmacy or medical benefit. No substitutions allowed.[1][2] - **Medicare/Medicaid**: **Not eligible**.[1] - **Employer retiree plans**: Often **not eligible**.[1] - If your plan requires copay card use or waives costs conditionally, eligibility/benefits may be limited—call 1-844-355-1499 to check.[1] The program is **not health insurance**. No reimbursement from FSAs/HSAs. Disclose participation if required.[1] ## Step-by-Step Application Process 1. **Get Prescribed**: Ask your doctor for TRUXIMA. Confirm commercial coverage.[4][5] 2. **Enroll in the Program**: Visit truxima.com or truximahcp.com/support-resources, or call **1-844-355-1499** (patients) or **1-888-587-3263** (general).[1][2] 3. **Receive Copay Card**: Activated upon eligibility verification. Use at pharmacy (PDMI Help Desk: 1-800-800-7364) or for medical claims.[1] 4. **For Pharmacy Claims**: - Pharmacist submits to PDMI as secondary coverage (COB segment, NCPDP).[1] 5. **For Medical Claims (Infusions)**: - Get TRUXIMA administered. - Submit **EOB** from insurance + **claim form** (CMS-1500/UB04/electronic) within **180 days** of EOB date. - Methods: Electronic (PAYER ID PSN22), Fax (1-858-630-4917), or call 1-844-355-1499.[1] - Covers up to 180 days prior enrollment, subject to limits.[1] 6. **Automatic Renewal**: Enrolled patients auto-renew next calendar year unless opted out or insurance changes.[1] **No online application URL** listed; phone/HCP sites primary.[2] ## Timeline and Delivery - **Processing**: Instant for copay card at pharmacy; medical claims processed post-submission (call for status).[1] - **Delivery**: Copay applied at point-of-service. Reimbursements via program (no specific time stated).[1] - **Benefit Reset**: Annual limits reset January 1.[1] - **Expiration**: Claims within 180 days; program terms ongoing.[1] Expect **as little as $0 per fill**, but varies by plan/expenses.[1][2] ## Alternatives If Denied or Ineligible - **Biosimilar Alternative**: **Rituxan (rituximab)**—Genentech offers copay program ($0 for commercial) and Patient Foundation for uninsured/low-income.[3][6][7] - **Other Options**: Genentech financial tool (888-249-4918), or check rxassist.org/Genentech programs.[3][10] - **Uninsured/Low-Income**: No Teva PAP for TRUXIMA; try Rituxan Patient Foundation (call 888-941-3331).[3] - **Teva CORE**: Oncology reimbursement help (tevacore.com).[8] ## Disclaimer This guide is for informational purposes only and based on available program details as of 2026. **Not medical/financial advice**. Eligibility, benefits, and terms can change—**always verify with 1-844-355-1499** or your provider. Teva may update limits/terms. Consult your doctor for treatment suitability. Program void where prohibited; follow state laws. © Teva Pharmaceuticals.[1]

Program information last verified: March 25, 2026